Generic placeholder image

Current Bioinformatics

Editor-in-Chief

ISSN (Print): 1574-8936
ISSN (Online): 2212-392X

Research Article

Bioinformatics Analysis Reveals Centromere Protein K Can Serve as Potential Prognostic Biomarker and Therapeutic Target for Non-small Cell Lung Cancer

Author(s): Yimin Luo, Xihua Wang, Li Li, Qun Wang, Yue Hu, Can He and Mei Zhang*

Volume 16, Issue 1, 2021

Published on: 28 July, 2020

Page: [106 - 119] Pages: 14

DOI: 10.2174/1574893615999200728100730

Price: $65

Abstract

Background: Non-small cell lung carcinoma (NSCLC) accounts for 80% of all lung cancer cases, which have been a leading cause of morbidity and mortality worldwide. Previous studies demonstrated that centromere proteins were dysregulated and involved in regulating the tumorigenesis and development of human cancers. However, the roles of centromere protein family members in NSCLC remained to be further elucidated.

Objective: The present study aimed to explore the roles of centromere protein family members in NSCLC.

Methods: GEPIA (http://gepia.cancer-pku.cn/) was used to analyze the target’s expression between normal and human cancers. We explored the prognostic value of centromere proteins in NSCLC using the Kaplan–Meier plotter (http://kmplot.com). The protein-protein interaction among centromere proteins was determined using GeneMANIA (http://www.genemania.org). TISIDB (http://cis.hku.hk/TISIDB) database was used to detect the relationship between centromere protein expression and clinical stages, lymphocytes, immunomodulators and chemokines in NSCLC. The DAVID database (https://david.ncifcrf.gov) was used to detect potential roles of CENPK using its co-expressing genes.

Results: The present study for the first time showed that centromere protein family members including CENPA, CENPF, CENPH, CENPI, CENPK, CENPM, CENPN, CENPO, CENPQ, CENPU were dysregulated and correlated to the poor prognosis of patients with LUAD. CENPK showed the greatest correlation with the prognosis of patients with NSCLC. We found that CENPK was significantly highly expressed in LUAD samples and overexpression of CENPK was remarkably correlated to the shorter OS and DFS in patients with a different stage of NSCLC. Of note, this study for the first time showed that CENPK was significantly correlated to the lymphocytes and immunomodulators using the TISIDB database.

Conclusion: In summary, CENPK can serve as a novel biomarker for the diagnosis of patients with NSCLC.

Keywords: Non-small cell lung cancer, CENPK, prognosis, therapeutic target, biomarker, lymphocytes.

Graphical Abstract
[1]
Chen W, Zheng R, Zeng H, Zhang S. The incidence and mortality of major cancers in China, 2012. Chin J Cancer 2016; 35(1): 73.
[http://dx.doi.org/10.1186/s40880-016-0137-8] [PMID: 27484217]
[2]
Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 2010; 10(11): 760-74.
[http://dx.doi.org/10.1038/nrc2947] [PMID: 20966921]
[3]
Dumont M, Fachinetti D. DNA sequences in centromere formation and function. Prog Mol Subcell Biol 2017; 56: 305-36.
[http://dx.doi.org/10.1007/978-3-319-58592-5_13] [PMID: 28840243]
[4]
McNulty SM, Sullivan BA. Centromere silencing mechanisms. Prog Mol Subcell Biol 2017; 56: 233-55.
[http://dx.doi.org/10.1007/978-3-319-58592-5_10] [PMID: 28840240]
[5]
Beh TT, Kalitsis P. The role of centromere defects in cancer. Prog Mol Subcell Biol 2017; 56: 541-54.
[http://dx.doi.org/10.1007/978-3-319-58592-5_22] [PMID: 28840252]
[6]
Cao Y, Xiong J, Li Z, et al. CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis. Mol Med Rep 2019; 20(4): 3661-70.
[http://dx.doi.org/10.3892/mmr.2019.10624] [PMID: 31485675]
[7]
Li H, Zhang H, Wang Y. Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression. Am J Cancer Res 2018; 8(5): 835-51.
[PMID: 29888106]
[8]
Wu W, Wu F, Wang Z, et al. CENPH inhibits rapamycin sensitivity by regulating GOLPH3-dependent mTOR signaling pathway in colorectal cancer. J Cancer 2017; 8(12): 2163-72.
[http://dx.doi.org/10.7150/jca.19940] [PMID: 28819418]
[9]
Lu G, Hou H, Lu X, et al. CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway. Oncol Rep 2017; 37(6): 3484-92.
[http://dx.doi.org/10.3892/or.2017.5602] [PMID: 28498417]
[10]
Wu X, Lin Y, Shi L, et al. Upregulation of centromere protein H is associated with progression of renal cell carcinoma. J Mol Histol 2015; 46(4-5): 377-85.
[http://dx.doi.org/10.1007/s10735-015-9635-2] [PMID: 26248586]
[11]
Liao WT, Wang X, Xu LH, et al. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer 2009; 115(7): 1507-17.
[http://dx.doi.org/10.1002/cncr.24128] [PMID: 19170237]
[12]
Komatsu M, Yoshimaru T, Matsuo T, et al. Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis. Int J Oncol 2013; 42(2): 478-506.
[http://dx.doi.org/10.3892/ijo.2012.1744] [PMID: 23254957]
[13]
Wang J, Li H, Xia C, et al. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1. OncoTargets Ther 2019; 12: 869-82.
[http://dx.doi.org/10.2147/OTT.S190061] [PMID: 30774374]
[14]
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 2017; 45(W1): W98-W102.
[http://dx.doi.org/10.1093/nar/gkx247] [PMID: 28407145]
[15]
Győrffy B, Surowiak P, Budczies J, Lánczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 2013; 8(12): e82241.
[http://dx.doi.org/10.1371/journal.pone.0082241] [PMID: 24367507]
[16]
Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function Nucleic Acids Res 2010; 38(Web Server issue): W214-20.
[http://dx.doi.org/10.1093/nar/gkq537]
[17]
Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 2019; 35(20): 4200-2.
[http://dx.doi.org/10.1093/bioinformatics/btz210] [PMID: 30903160]
[18]
Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4(1): 44-57.
[http://dx.doi.org/10.1038/nprot.2008.211] [PMID: 19131956]
[19]
Liu WT, Wang Y, Zhang J, et al. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma. Cancer Lett 2018; 425: 43-53.
[http://dx.doi.org/10.1016/j.canlet.2018.03.043] [PMID: 29608985]
[20]
Chen EB, Qin X, Peng K, et al. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis. Aging 2019; 11(18): 7473-91.
[http://dx.doi.org/10.18632/aging.102254] [PMID: 31527303]
[21]
Shahid M, Kim M, Lee MY, et al. Downregulation of CENPF remodels prostate cancer cells and alters cellular metabolism. Proteomics 2019; 19(11): e1900038.
[http://dx.doi.org/10.1002/pmic.201900038] [PMID: 30957416]
[22]
Yamashita A, Ito M, Takamatsu N, Shiba T. Characterization of Solt, a novel SoxLZ/Sox6 binding protein expressed in adult mouse testis. FEBS Lett 2000; 481(2): 147-51.
[http://dx.doi.org/10.1016/S0014-5793(00)01987-6] [PMID: 10996314]
[23]
Iguchi H, Urashima Y, Inagaki Y, et al. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem 2007; 282(26): 19052-61.
[http://dx.doi.org/10.1074/jbc.M700460200] [PMID: 17412698]
[24]
Dejima H, Kuroda H, Oya Y, et al. Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis. J Thorac Dis 2018; 10(12): 6932-41.
[http://dx.doi.org/10.21037/jtd.2018.11.40] [PMID: 30746239]
[25]
Jeong H, Kim S, Hong BJ, et al. Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis. Cancer Res 2019; 79(4): 795-806.
[http://dx.doi.org/10.1158/0008-5472.CAN-18-2545] [PMID: 30610087]
[26]
Shi J, Wang H, Feng W, et al. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells. Eur J Pharmacol 2019; 862: 172615.
[http://dx.doi.org/10.1016/j.ejphar.2019.172615] [PMID: 31422060]
[27]
Navarro A, Moises J, Santasusagna S, et al. Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer. BMC Pulm Med 2019; 19(1): 55.
[http://dx.doi.org/10.1186/s12890-019-0816-8] [PMID: 30819158]
[28]
Sang Y, Zhou F, Wang D, et al. Up-regulation of long non-coding HOTTIP functions as an oncogene by regulating HOXA13 in non-small cell lung cancer. Am J Transl Res 2016; 8(5): 2022-32.
[PMID: 27347311]
[29]
Hua Q, Jin M, Mi B, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol 2019; 12(1): 91.
[http://dx.doi.org/10.1186/s13045-019-0773-y] [PMID: 31488218]
[30]
Khan P, Bhattacharya A, Sengupta D, Banerjee S, Adhikary A, Das T. Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. Sci Rep 2019; 9(1): 16913.
[http://dx.doi.org/10.1038/s41598-019-53134-0] [PMID: 31729456]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy